| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,904 |
12,615 |
$2.58M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,660 |
14,360 |
$2.14M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
46,076 |
36,069 |
$1.38M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,340 |
2,622 |
$789K |
| G0378 |
Hospital observation service, per hour |
2,462 |
1,305 |
$333K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
857 |
476 |
$93K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,952 |
16,649 |
$65K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
754 |
654 |
$63K |
| 80053 |
Comprehensive metabolic panel |
21,528 |
16,368 |
$54K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,789 |
1,539 |
$53K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
654 |
253 |
$39K |
| 36415 |
Collection of venous blood by venipuncture |
24,133 |
18,400 |
$35K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,014 |
2,463 |
$26K |
| 84484 |
|
3,130 |
2,175 |
$24K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,003 |
687 |
$20K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
475 |
447 |
$14K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
488 |
372 |
$14K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,082 |
2,069 |
$8K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,081 |
841 |
$7K |
| 80306 |
|
865 |
715 |
$7K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
246 |
194 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,806 |
1,541 |
$7K |
| 92134 |
|
1,163 |
813 |
$7K |
| 81001 |
|
11,466 |
9,650 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
161 |
113 |
$6K |
| 81025 |
|
3,346 |
3,011 |
$6K |
| 20610 |
|
87 |
68 |
$6K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
409 |
319 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,828 |
1,022 |
$5K |
| 92002 |
|
194 |
158 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,298 |
1,202 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
2,191 |
1,718 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,059 |
1,657 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
423 |
346 |
$3K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
27 |
25 |
$3K |
| 90686 |
|
404 |
361 |
$3K |
| 80061 |
Lipid panel |
900 |
733 |
$3K |
| 85610 |
|
1,318 |
999 |
$2K |
| 85730 |
|
987 |
773 |
$2K |
| 85027 |
|
1,654 |
807 |
$2K |
| 82550 |
|
952 |
592 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
337 |
294 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
120 |
60 |
$2K |
| 83880 |
|
320 |
249 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
122 |
27 |
$2K |
| 81000 |
|
890 |
766 |
$1K |
| 96417 |
|
40 |
24 |
$1K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
270 |
131 |
$1K |
| 92250 |
|
44 |
36 |
$1K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
18 |
12 |
$1K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
15 |
14 |
$1K |
| 70450 |
Computed tomography, head or brain; without contrast material |
36 |
26 |
$1K |
| 92015 |
Determination of refractive state |
281 |
219 |
$1K |
| 87486 |
|
179 |
128 |
$1K |
| 87581 |
|
179 |
128 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
179 |
128 |
$1K |
| 82652 |
|
188 |
152 |
$964.81 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
181 |
166 |
$878.07 |
| 84481 |
|
85 |
74 |
$829.29 |
| 87400 |
|
622 |
543 |
$806.59 |
| 84153 |
|
431 |
323 |
$773.20 |
| 82553 |
|
572 |
358 |
$739.01 |
| 84439 |
|
189 |
168 |
$668.45 |
| 83690 |
|
233 |
189 |
$581.89 |
| 87070 |
|
137 |
122 |
$537.42 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
18 |
18 |
$532.08 |
| 83735 |
|
244 |
195 |
$493.08 |
| 71046 |
Radiologic examination, chest; 2 views |
173 |
138 |
$485.78 |
| Q3014 |
Telehealth originating site facility fee |
27 |
26 |
$456.72 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
13 |
$447.95 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
13 |
$447.95 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
17 |
13 |
$359.17 |
| 86769 |
|
39 |
27 |
$320.00 |
| 80074 |
|
12 |
12 |
$296.09 |
| 83605 |
|
48 |
36 |
$282.34 |
| 86160 |
|
14 |
14 |
$233.38 |
| 85651 |
|
106 |
98 |
$218.22 |
| 94664 |
|
63 |
54 |
$214.70 |
| 85014 |
|
284 |
215 |
$214.27 |
| 85018 |
|
284 |
215 |
$211.81 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
63 |
54 |
$202.83 |
| 80069 |
|
145 |
101 |
$178.19 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
44 |
40 |
$152.28 |
| 84100 |
|
368 |
296 |
$142.88 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
66 |
37 |
$108.56 |
| 11721 |
|
16 |
14 |
$103.95 |
| 86140 |
|
52 |
47 |
$92.38 |
| 87205 |
|
59 |
51 |
$89.04 |
| 92020 |
|
24 |
12 |
$78.09 |
| 86225 |
|
12 |
12 |
$71.48 |
| 86256 |
|
12 |
12 |
$70.16 |
| 92133 |
|
29 |
13 |
$68.56 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
15 |
12 |
$58.85 |
| 11719 |
|
58 |
40 |
$52.38 |
| 81003 |
|
58 |
51 |
$29.70 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
344 |
323 |
$25.82 |
| 96376 |
|
36 |
13 |
$10.70 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
32 |
26 |
$10.60 |
| J2704 |
Injection, propofol, 10 mg |
183 |
149 |
$7.52 |
| 0064A |
|
17 |
12 |
$0.05 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
14 |
12 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
218 |
107 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
19 |
13 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
13 |
12 |
$0.00 |